SCHEMBL9760976

SCHEMBL9760976

O=C(c1ccccc1)c1ccc([N+](=O)[O-])c(C(=O)NCc2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.59
CYP1A2 P05177 2/20 0.59
CYP3A4 P08684 2/20 0.59
CYP2C19 P33261 2/20 0.59
SIRT6 Q8N6T7 1/20 0.58
MAPK1 P28482 1/20 0.54
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
POLB P06746 1/20 0.53
HTT P42858 1/20 0.52
VCAM1 P19320 1/20 0.51
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
FFAR1 O14842 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9760868 0.84 MAPK1 (0.59) HPGDMAPK1KMT2AMEN1POLB
SCHEMBL21296309 0.82 HPGD (0.63) HPGDCYP1A2CYP3A4CYP2C19SIRT6
SCHEMBL28676043 0.82 HPGD (0.62) HPGDCYP1A2CYP3A4CYP2C19SIRT6
SCHEMBL19246188 0.81 KMT2A (0.75) HPGDCYP1A2CYP3A4CYP2C19SIRT6
SCHEMBL30236290 0.81 KMT2A (0.75) HPGDCYP1A2CYP3A4CYP2C19SIRT6
SCHEMBL27214426 0.81 POLB (0.56) HPGDCYP1A2CYP3A4CYP2C19SIRT6
SCHEMBL18766936 0.81 SIRT6 (0.52) HPGDCYP1A2CYP3A4CYP2C19SIRT6
SCHEMBL8302813 0.80 SMN1; SMN2 (0.60) HPGDCYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL9199250 0.80 MAPK1 (0.68) MAPK1KMT2AMEN1POLBVCAM1
SCHEMBL27943660 0.80 HTR6 (0.57) CYP1A2CYP3A4CYP2C19SIRT6MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1036002-C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives JANSSEN PHARMACEUTICA NV (BE) 1997-10-01 CN disclosed
CN-1033752-C (1H-azol-1-ylmethyl) substituted quinoline or quinolinone derivatives JANSSEN PHARMACEUTICA NV (SE) 1997-01-08 CN disclosed
CN-1106005-A A process for preparing (1H-azol-1-ylmethyl) substituted quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-08-02 CN disclosed
CN-1106004-A A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-08-02 CN disclosed
US-5037829-A Antitumor Activity; Androgen, Estrogen Inhibitors; Suppress The Plasma Elimination Of Retinoids JANSSEN PHARMACEUTICA N.V. (BE) 1991-08-06 US disclosed
CN-1042912-A (1H-oxazol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1990-06-13 CN disclosed